Clinical trial
Osteoporosis Prevention After Heart Transplant
NCT00000412 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00000412 |
|---|---|
| Title | Osteoporosis Prevention After Heart Transplant |
| Official title | Prevention of Osteoporosis After Cardiac Transplantation |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Cardiac Transplantation |
| Intervention type | Drug |
| Interventions | Alendronate, Calcitriol, Placebo Alendronate, Placebo Calcitriol |
| Enrollment | 149 |
| Start date | Sep 1, 1997 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: